Duplication 1q is highly correlated with poor prognosis in high hyperdiploid pediatric B-acute lymphoblastic leukemia

© 2020 John Wiley & Sons Ltd..

BACKGROUND: The role of structural abnormalities in high hyperdiploidy (HeH) has been debatable, with few studies that addressed recurrent translocations with concurrent HeH (t-HeH). We aimed at the characterization of HeH cases in pediatric B-acute lymphoblastic leukemia (B-ALL) patients with special emphasis on the structural abnormalities including t-HeH.

PATIENTS AND METHODS: Our study included all patients diagnosed with HeH over the period from January 2016 to April 2019 presenting to the Pediatric Oncology Department, National Cancer Institute, Cairo University.

RESULTS: Among 480 de novo B-ALL pediatric patients, HeH was detected in eighty (16.7%) cases with a median age of 5 years. t-HeH was identified in 17/480 (3.5%) cases: 9(1.9%) with t(12;21), 7(1.5%) with t(9;22), and 1(0.2%) with t(4;11). Duplication (1q) was the most prevalent structural abnormality in c-HeH (hyperdiploidy without recurrent translocations) (n = 12,15%). Children ≥10 years or presenting with white blood cells (WBC) ≥50 × 109 /L) had an inferior 3 year-overall survival as compared to younger children (P = .003), and to lower WBC (P = .02). Duplication (1q) was an independent adverse parameter on the disease-free survival (DFS) of c-HeH patients (P = .004).

CONCLUSIONS: Older age and WBC ≥ 50 × 109 /L were adverse prognostic factors. Duplication (1q) is correlated with lower DFS in c-HeH patients. t-HeH has distinct patterns of chromosomal gain.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:43

Enthalten in:

International journal of laboratory hematology - 43(2021), 2 vom: 21. Apr., Seite 235-243

Sprache:

Englisch

Beteiligte Personen:

El Ashry, Mona S [VerfasserIn]
Elsayed, Ghada M [VerfasserIn]
Madney, Youssef [VerfasserIn]
Arafah, Omar [VerfasserIn]
Allam, Rasha M [VerfasserIn]
Rasekh, Eman O [VerfasserIn]

Links:

Volltext

Themen:

B-ALL
Biomarkers
Duplication (1q)
HeH
Journal Article
Prognosis
T-HeH

Anmerkungen:

Date Completed 07.06.2021

Date Revised 07.06.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/ijlh.13369

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM316433233